LRP8 and acute myeloid leukemia: Thus, LRP8 blockade represents a rational strategy to indirectly deplete GPX4 and selectively trigger ferroptosis in MYCN‐amplified neuroblastoma and potentially other entities with low system Xc− expression/activity such as AML and lymphoma, while sparring normal cells.